TIGIT+ CD4+ regulatory T cells enhance PD-1 expression on CD8+ T cells and promote tumor growth in a murine ovarian cancer model
Abstract Immune checkpoint-based immunotherapy has shown limited efficacy in the treatment of ovarian cancer. In recent years, the emergence of immune checkpoint co-targeting therapies, led by the combination targeting of TIGIT and FAK, has shown promise in ovarian cancer treatment. Our preliminary...
        Saved in:
      
    
          | Main Authors: | Fengzhen Chen, Yanying Xu, Xiangyu Liu, Na Dong, Lei Tian | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMC
    
        2024-12-01 | 
| Series: | Journal of Ovarian Research | 
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13048-024-01578-y | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction        
                          
 by: Marius Witt, et al.
 Published: (2024-12-01)
- 
                
                    Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor        
                          
 by: Jingjing Zhao, et al.
 Published: (2023-12-01)
- 
                
                    Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves Trogocytosis        
                          
 by: Nazanin Ghasemi, et al.
 Published: (2024-12-01)
- 
                
                    Emerging roles of checkpoint molecules on B cells        
                          
 by: Hiromitsu Asashima, et al.
 Published: (2025-01-01)
- 
                
                    Studying TIGIT activity against tumors through the generation of knockout mice        
                          
 by: Ahmed Rishiq, et al.
 Published: (2023-12-01)
 
       